Featured Research

from universities, journals, and other organizations

New Investigational Vaccine To Prevent Hepatitis C Tested For First Time In Humans

Date:
November 17, 2003
Source:
Saint Louis University
Summary:
With an estimated 170 million people around the world already infected with hepatitis C, Saint Louis University is testing, for the first time in humans, an investigational vaccine that researchers hope will prevent infection with the virus.

ST. LOUIS - With an estimated 170 million people around the world already infected with hepatitis C, Saint Louis University is testing, for the first time in humans, an investigational vaccine that researchers hope will prevent infection with the virus. The successful development of such a vaccine would represent a major step in combating this growing health problem.

Saint Louis University is the only site in the country conducting this pilot study.

"There is currently no licensed vaccine to protect against the hepatitis C virus," said Sharon Frey, M.D., principal investigator for the study and associate professor of internal medicine at Saint Louis University School of Medicine. "Our research is important because infection with hepatitis C virus is a major health problem throughout the world. It is believed that 2.7 million Americans have chronic infection with this virus, and up to 170 million people may have chronic infection with hepatitis C virus throughout the world."

The purpose of this research is to study the safety and effectiveness of three different strengths of the Chiron Corporation's investigational hepatitis vaccine.

"This is the first time this hepatitis vaccine will be tested in humans," Frey said. "A vaccine to prevent the infection would be an important breakthrough in controlling the spread of the hepatitis C virus."

The study is being conducted by Saint Louis University's Center for Vaccine Development (led by the division of infectious diseases and immunology) in collaboration with Saint Louis University Liver Center (led by the school's division of gastroenterology and hepatology). This research is sponsored by the National Institutes of Health and Chiron.

Hepatitis C virus is a blood-borne infection that causes approximately 10,000 deaths annually and is responsible for almost half of the 4,000 liver transplants each year. The Centers for Disease Control and Prevention estimates medical and work-loss costs for hepatitis C at more than $600 million annually, excluding the costs of transplantation. In the United States alone, the Centers for Disease Control believe that approximately 40,000 new cases of hepatitis C infections occur every year.

###

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research and provides health services on a local, national and international level.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "New Investigational Vaccine To Prevent Hepatitis C Tested For First Time In Humans." ScienceDaily. ScienceDaily, 17 November 2003. <www.sciencedaily.com/releases/2003/11/031117073403.htm>.
Saint Louis University. (2003, November 17). New Investigational Vaccine To Prevent Hepatitis C Tested For First Time In Humans. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2003/11/031117073403.htm
Saint Louis University. "New Investigational Vaccine To Prevent Hepatitis C Tested For First Time In Humans." ScienceDaily. www.sciencedaily.com/releases/2003/11/031117073403.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins